To evaluate changes in its DNA and RNA makeup in tumor in hormone therapy resistant breast cancer
Not Applicable
- Conditions
- Health Condition 1: null- Locally advance breast cancerMetastatic Breast Cancer
- Registration Number
- CTRI/2017/11/010553
- Lead Sponsor
- Department of Biotechnology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Locally advanced breast cancer and Metastatic breast cancer
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To identify major pathways through which a tumour becomes resistant to endocrine therapyTimepoint: At first relapse
- Secondary Outcome Measures
Name Time Method ATimepoint: NA